Heavily immunosuppressed patients undergoing anticancer immunotherapy face increased risk of severe infections
Immune checkpoint inhibitors (ICIs) can promote antitumor responses but can also cause adverse effects that require treatment with immunosuppressive drugs. A new retrospective study by Mass General Brigham Cancer Institute investigators found that patients who received ICIs and multiple immunosuppressive therapies were at higher risk of serious infections. Nearly half of the infections were…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
USP15 enzyme emerges as potential target for ovarian cancer treatment
-
Uterus transplantation shows improving outcomes and successful births nationwide
-
The heart effects of antidepressants may depend as much on the patient as the drug
-
AI model predicts immunotherapy-related pneumonitis risk from CT scans
-
Investigating brain stimulation as an alternative to medication in the treatment of epilepsy
-
Study identifies shared pathway driving cardiac fibrosis
-
Overprescribing can take a toll on older people's health and independence—here's what can be done
-
Beetroot juice may make swimming feel easier without making swimmers faster